SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001538210-23-000017
Filing Date
2023-05-15
Accepted
2023-05-15 16:03:57
Documents
14
Period of Report
2023-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexi-20230515.htm   iXBRL 8-K 39611
2 EX-99.1 nexi-20230331xexx991.htm EX-99 72341
6 image_0.jpg GRAPHIC 3409
  Complete submission text file 0001538210-23-000017.txt   267581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20230515.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20230515_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20230515_pre.xml EX-101.PRE 13045
8 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20230515_htm.xml XML 12358
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 23921880
SIC: 2834 Pharmaceutical Preparations